Pharmacokinetics of BPDO-1603 or BPDO-16031 and BPDO-16033 Administration in Healthy Adults
Clinical trial NCT05804279 · COMPLETED
Trial details
- NCT number
- NCT05804279
- Sponsor
- Hyundai Pharm
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-28
- Primary completion
- 2023-02-21
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.